C

    CEL-SCI Corp (CVM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $1.61
    +0.05 (+3.21%)

    Market Cap: $27.44M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    13%(3/24)
    Avg Surprise
    -163.73%
    Streak
    1 Q
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    		$-0.47N/AN/ABeat+79.8%
    Dec 25
    		$-0.68$0.00N/AMiss+74.8%
    Sep 25
    		$-0.86N/AN/ABeat+68.2%
    Jun 25
    		$-1.36N/AN/ABeat+67.6%
    Mar 25
    		$-2.33N/AN/ABeat+72.2%
    Dec 24
    		$-2.70$-3.30+18.18%Beat+35.7%
    Sep 24
    		$-2.70$-0.10-2600.30%Miss-1587.7%
    Jun 24
    		$-4.20$-3.90-7.69%Miss+26.3%
    Mar 24
    		$-8.40$-4.20-100.00%Miss-47.4%
    Dec 23
    		$-4.20$-4.20+0.00%Beat+22.2%
    Sep 23
    		$-0.16$-0.16+0.00%Beat+23.8%
    Jun 23
    		$-5.70$-4.50-26.67%Miss+17.4%
    Mar 23
    		$-5.70$-5.10-11.76%Miss+17.4%
    Dec 22
    		$-5.40$-3.00-80.00%Miss-2600.0%
    Sep 22
    		$-0.21$-0.20-5.00%Miss+96.3%
    Jun 22
    		$-6.90$-2.70-155.56%Miss-4.5%
    Mar 22
    		$-6.90$-2.70-155.56%Miss+17.9%
    Dec 21
    		$-0.20$-0.19-5.26%Miss+4.8%
    Sep 21
    		$-5.70$-3.00-90.00%Miss-35.7%
    Jun 21
    		$-6.60$-3.90-69.23%Miss+18.5%
    Mar 21
    		$-8.40$-5.70-47.37%Miss-12.0%
    Dec 20
    		$-0.21$-0.15-40.00%Miss-31.2%
    Sep 20
    		$-4.20$-3.00-40.00%Miss-7.7%
    Jun 20
    		$-8.10$-5.70-42.11%Miss+27.0%
    Mar 20
    		$-7.50$-4.50-66.67%Miss-3309.1%
    Dec 19
    		$-0.16$-0.15-6.67%Miss-500.0%
    Sep 19
    		$-3.90$-2.70-44.44%Miss-482.1%
    Jun 19
    		$-11.10$-3.00-270.00%Miss-2983.3%
    Mar 19
    		$-0.22$-0.12-83.33%Miss+29.0%
    Dec 18
    		$0.04N/AN/ABeat+107.5%
    Sep 18
    		$-0.67N/AN/ABeat-31.4%
    Jun 18
    		$-0.36N/AN/ABeat+32.1%
    Mar 18
    		$-0.31N/AN/ABeat+75.2%
    Dec 17
    		$-0.53N/AN/ABeat-312.0%
    Sep 17
    		$-0.51$0.00N/AMiss-174.0%
    Jun 17
    		$-0.53N/AN/ABeat-
    Mar 17
    		$-1.25N/AN/ABeat-
    Dec 16
    		$0.25N/AN/ABeat-
    Sep 16
    		$-0.19N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.48EV/EBITDA11.00x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-252.50%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage-50.19x
    Current Ratio1.48xQuick Ratio1.42x
    Trading Statistics
    Beta0.56Avg Volume209.40K
    52-Week High$12.6852-Week Low$0.89

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.53
    SMA 20$1.53
    SMA 50$1.32
    SMA 200$3.43
    EMA 10$1.54
    EMA 20$1.49
    EMA 50$1.49
    EMA 200$3.22

    MACD

    Line: 0.06Signal: 0.06Hist: 0.00

    ADX

    ADX: 28.2+DI: 31.2-DI: 18.9

    Aroon & PSAR

    Aroon Up40.0
    Aroon Down8.0
    PSAR$1.36

    Bollinger Bands

    Upper Band$1.71
    Lower Band$1.35
    %B Position2352%(Upper)
    Band Width0.72

    RSI (14-Day)

    Neutral
    58.5

    Momentum Oscillators

    Stoch %K66.7
    Stoch %D61.8
    Williams %R-25.0
    ROC (10d)3.9%
    Momentum0.06
    CCI (20d)55.2
    MFI (14d)58.4

    Volatility Measures

    ATR (14d)$0.12(7.7%)
    StdDev (20d)0.09
    Hist Vol100.1%(High)

    Volume Flow

    VWAP$1.59
    OBV-56.2M
    AD Line43.5B
    CMF (20d)0.072

    Volume Metrics

    Avg Vol (20d)186.5K
    Vol Ratio0.3x(Low)
    VWMA (20d)$1.54

    Pivot Points

    R3$1.69
    R2$1.65
    R1$1.60
    Pivot Point$1.56
    S1$1.52
    S2$1.48
    S3$1.44

    Advanced Oscillators

    TSI13.68
    Ultimate Osc49.8
    KST223.72

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0$0$960,850$0$0$0N/A$0$0$0$998,653
    Gross Profit$0$0$0$-960,850$0$0$0N/A$0$0$0$-998,653
    Operating Expenses$5.56M$5.33M$5.37M$6.03M$5.49M$6.39M$6.89M$6.12M$6.67M$7.08M$6.49M$7.47M
    R&D$3.65M$3.77M$3.68M$3.70M$3.74M$4.01M$4.43M$4.48M$4.70M$4.63M$4.35M$5.27M
    SG&A$1.91M$1.56M$1.69M$2.33M$1.75M$2.38M$2.46M$1.64M$1.97M$2.45M$2.13M$2.20M
    Operating Income$-5,557,285$-5,326,009$-5,368,806$-6,033,332$-5,488,883$-6,394,103$-6,893,418$-6,120,404$-6,670,235$-7,075,948$-6,485,887$-7,467,522
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$110,240$117,485$87,789$128,505$172,050$178,286$170,103$174,571$190,705$182,701$197,696$500,020
    Income Before Tax$-5,667,525$-5,443,494$-5,456,595$-6,161,837$-5,660,933$-6,572,389$-7,063,521$-6,308,733$-6,860,940$-7,244,891$-6,683,583$-7,963,688
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-5,667,525$-5,465,751$-5,469,446$-6,100,900$-5,664,704$-6,572,389$-7,073,062$-6,109,492$-6,856,558$-7,244,891$-6,709,524$-7,630,704
    EBITDA$-4,610,915$-4,369,608$-4,404,384$-5,072,482$-4,529,874$-5,424,001$-5,898,226$-5,128,824$-5,686,027$-6,073,428$-5,481,254$-6,468,869
    EBIT$-5,557,285$-5,326,009$-5,368,806$-6,033,332$-5,488,883$-6,394,103$-6,893,418$-6,120,404$-6,670,235$-7,062,190$-6,485,887$-7,467,522
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CVM

    News

    Form 8K CEL-SCI Corp For: 17 August By Investing.com

    This article reports on a Form 8K filing by CEL-SCI Corp for August 17th. It is a brief news item from Investing.com, typical of regulatory filing announcements. The article primarily serves as an alert to the filing rather than providing detailed analysis.

    Investing.com Nigeria•8/18/26•
    Neutral

    CEL-SCI Company Profile & Introduction

    This document provides a company profile and introduction for CEL-SCI. It is likely an overview of their operations, mission, and perhaps their position in the biotechnology or pharmaceutical industry. Further details would be contained within the document itself.

    Moomoo•8/18/26•
    Neutral

    CEL-SCI (NYSE: CVM) awards Cipriano 80K options vesting over 3 years

    CEL-SCI Corp (NYSE: CVM) has granted Senior Vice President John Cipriano 80,000 stock options with an exercise price of $1.49 per share. These options, which have a stated value of $0.01 per option and expire in 2036, will vest in three equal annual installments starting one year from the grant date of August 14, 2026. Following this transaction, Cipriano directly holds a total of 118,010 options.

    Stock Titan•8/18/26•
    Neutral

    CEL-SCI (NYSEAMERICAN: CVM) CFO lands new 2036 stock option grant

    CEL-SCI Corp.'s CFO, Patricia B. Prichep, has been granted 225,000 stock options with an exercise price of $1.49 per share. These options, which have a reported transaction price of $0.01 per option, are set to expire on August 13, 2036, and will vest in three equal annual installments beginning one year from the grant date. Following this award, Ms. Prichep now holds a total of 299,693 options in the company.

    Stock Titan•8/18/26•
    Neutral

    CEL-SCI (NYSE: CVM) awards CEO 300,000 options over 3 years

    CEL-SCI (NYSE: CVM) CEO Geert R. Kersten was granted 300,000 stock options on August 14, 2026. These options have an exercise price of $1.49 per share, a grant-date fair value of $0.01 per option, and will vest in three equal annual installments over three years. Following this grant, Kersten directly holds a total of 452,380 options in the company.

    Stock Titan•8/17/26•
    Neutral

    Frequently Asked Questions About CVM

    Does CVM pay dividends?
    CEL-SCI Corp (CVM) does not currently pay a regular dividend.
    What is CVM's market cap?
    CEL-SCI Corp (CVM) has a market capitalization of $27.44M with a current stock price of $1.61.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In